New data publicly available on physician, hospital quality
January 28, 2015
During the 2014 holiday season, a large amount of Medicare data was released on physician and hospital quality measure results, including some accountable care organizations.
The Physician Compare website published select quality measures reported under the 2013 physician quality reporting system for 139 group practices, 214 Shared Savings Program Accountable Care Organizations, and 23 Pioneer ACOs. The measures being displayed include:
- Controlling blood sugar levels in patients with diabetes
- Controlling blood pressure in patients with diabetes
- Prescribing aspirin to patients with diabetes and heart disease
- Prescribing medicine to improve the pumping action of the heart in patients who have both heart disease and certain other conditions
- (ACOs only) Four patient experience of care survey measures
Performance scores on each measure for the group practices are displayed as stars followed by a percent, with each star representing 20 percent. CMS plans to significantly expand the number of quality measures available for public reporting on Physician Compare. In late 2015, CMS will post quality measures for groups of all sizes and a subset of quality measures for individual physicians.
Additional information about Physician Compare can be found here.
The Hospital Compare website now includes results of the first year of the Hospital-Acquired Condition Reduction program and third-year results from the hospital Value-Based Purchasing Program.
- Information about the HAC Reduction program can be found here.
- The Hospital VBP Program adjustment factors are available here.
In addition, Hospital Compare will now include the following hospital-reported quality measures:
- Care Transition survey measure
- Healthcare Provider Influenza measure
- 30-day risk-standardized mortality and readmission rates for COPD and stroke
- 30-day episode of care payment measure for heart attack patients
- PPS-Exempt Cancer Hospital Quality Reporting Program reports on adjuvant chemotherapy colon cancer and combination chemotherapy breast cancer
For more information, please contact Christa Shively, director, federal regulatory and engagement for Providence.